Ambrx Biopharma ROA 2020-2022 | AMAM
Current and historical return on assets (ROA) values for Ambrx Biopharma (AMAM) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Ambrx Biopharma ROA - Return on Assets Historical Data |
Date |
TTM Net Income |
Total Assets |
Return on Assets |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.335B |
$0.007B |
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
|